NO20091293L - Preparation and purification of mupirocin calcium - Google Patents
Preparation and purification of mupirocin calciumInfo
- Publication number
- NO20091293L NO20091293L NO20091293A NO20091293A NO20091293L NO 20091293 L NO20091293 L NO 20091293L NO 20091293 A NO20091293 A NO 20091293A NO 20091293 A NO20091293 A NO 20091293A NO 20091293 L NO20091293 L NO 20091293L
- Authority
- NO
- Norway
- Prior art keywords
- mupirocin
- purification
- preparation
- calcium
- resin
- Prior art date
Links
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title abstract 5
- 229960000313 mupirocin calcium Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 abstract 3
- 229960003128 mupirocin Drugs 0.000 abstract 3
- 229930187697 mupirocin Natural products 0.000 abstract 3
- 239000011347 resin Substances 0.000 abstract 3
- 229920005989 resin Polymers 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000003463 adsorbent Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Den foreliggende oppfinnelse angår metoder for fremstilling og rensing av mupirocinkalsium. Prosessen omfatter å adsorbere mupirocin til en hydrofob adsorbentresin, eksponere det bundne mupirocin til en kalsiuminneholdende løsning, vaske urenheter vekk fra resinet og eluere renset mupirocin fra resinet.The present invention relates to methods for the preparation and purification of mupirocin calcium. The process includes adsorbing mupirocin to a hydrophobic adsorbent resin, exposing the bound mupirocin to a calcium-containing solution, washing impurities away from the resin, and eluting purified mupirocin from the resin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0617069A GB2441328A (en) | 2006-08-30 | 2006-08-30 | A method for obtaining mupirocin calcium |
| PCT/EP2007/007547 WO2008025534A1 (en) | 2006-08-30 | 2007-08-29 | Preparation and purification of mupirocin calcium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20091293L true NO20091293L (en) | 2009-03-27 |
| NO342269B1 NO342269B1 (en) | 2018-04-30 |
Family
ID=37137032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091293A NO342269B1 (en) | 2006-08-30 | 2009-03-27 | Preparation and purification of mupirocin calcium |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7868191B2 (en) |
| EP (1) | EP2081926B1 (en) |
| JP (1) | JP5277167B2 (en) |
| CN (1) | CN101511826B (en) |
| AT (1) | ATE556073T1 (en) |
| AU (1) | AU2007291508B2 (en) |
| CA (1) | CA2649758C (en) |
| GB (1) | GB2441328A (en) |
| NO (1) | NO342269B1 (en) |
| PL (1) | PL2081926T3 (en) |
| TW (1) | TWI406860B (en) |
| WO (1) | WO2008025534A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2441328A (en) | 2006-08-30 | 2008-03-05 | Alpharma Aps | A method for obtaining mupirocin calcium |
| CN101591333B (en) * | 2009-07-02 | 2012-01-04 | 山东健威生物工程有限公司 | Method for purifying pseudomonas acid A |
| CN104370896A (en) * | 2013-11-29 | 2015-02-25 | 江苏汉邦科技有限公司 | Pseudomonas elodea rhzomorph purifying method |
| WO2022042299A1 (en) * | 2020-08-25 | 2022-03-03 | 杭州中美华东制药有限公司 | Method for extracting mupirocin |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3977943A (en) * | 1971-06-12 | 1976-08-31 | Beecham Group Limited | Antibiotics |
| US4071536A (en) * | 1971-06-12 | 1978-01-31 | Beecham Group Limited | Antibiotics |
| GB1395907A (en) | 1971-06-12 | 1975-05-29 | Beecham Group Ltd | Antibiotics |
| CA1103264A (en) * | 1977-09-30 | 1981-06-16 | Norman H. Rogers | Purification of pseudomonic acid |
| CA1115699A (en) * | 1978-05-20 | 1982-01-05 | Alan D. Curzons | Lithium pseudomonate and its preparation |
| GB8415579D0 (en) * | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
| JPH01268682A (en) * | 1988-04-21 | 1989-10-26 | Minofuaagen Seiyaku Honpo:Goushi | Renal function improver and production of lithospermate |
| US5235037A (en) * | 1991-08-15 | 1993-08-10 | American Cyanamid Company | Vancomycin precipitation process |
| AU771214B2 (en) * | 1999-02-03 | 2004-03-18 | Teva Gyogyszergyar Reszvenytarsasag | Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
| IL162457A0 (en) * | 2001-12-28 | 2005-11-20 | Biogal Pharmaceutical Co | Processes for preparing crystalline and amorphous mupirocin calcium |
| ATE458476T1 (en) * | 2004-06-01 | 2010-03-15 | Teva Gyogyszergyar Zartkoeruen | METHOD FOR PREPARING THE AMORPHIC FORM OF A MEDICATION |
| AU2006215708B2 (en) * | 2005-02-21 | 2011-01-27 | Syngen Biotech Co., Ltd | Purification of mupirocin |
| GB2441328A (en) | 2006-08-30 | 2008-03-05 | Alpharma Aps | A method for obtaining mupirocin calcium |
-
2006
- 2006-08-30 GB GB0617069A patent/GB2441328A/en not_active Withdrawn
-
2007
- 2007-08-28 TW TW096131791A patent/TWI406860B/en active
- 2007-08-29 US US12/310,216 patent/US7868191B2/en active Active
- 2007-08-29 JP JP2009525975A patent/JP5277167B2/en active Active
- 2007-08-29 WO PCT/EP2007/007547 patent/WO2008025534A1/en not_active Ceased
- 2007-08-29 CN CN2007800319710A patent/CN101511826B/en active Active
- 2007-08-29 PL PL07801968T patent/PL2081926T3/en unknown
- 2007-08-29 AU AU2007291508A patent/AU2007291508B2/en active Active
- 2007-08-29 AT AT07801968T patent/ATE556073T1/en active
- 2007-08-29 CA CA2649758A patent/CA2649758C/en active Active
- 2007-08-29 EP EP07801968A patent/EP2081926B1/en active Active
-
2009
- 2009-03-27 NO NO20091293A patent/NO342269B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007291508A1 (en) | 2008-03-06 |
| TW200825070A (en) | 2008-06-16 |
| CA2649758A1 (en) | 2008-03-06 |
| CN101511826B (en) | 2011-06-22 |
| US20090240071A1 (en) | 2009-09-24 |
| PL2081926T3 (en) | 2012-12-31 |
| GB0617069D0 (en) | 2006-10-11 |
| ATE556073T1 (en) | 2012-05-15 |
| GB2441328A (en) | 2008-03-05 |
| AU2007291508B2 (en) | 2011-11-24 |
| JP5277167B2 (en) | 2013-08-28 |
| JP2010501608A (en) | 2010-01-21 |
| WO2008025534A1 (en) | 2008-03-06 |
| NO342269B1 (en) | 2018-04-30 |
| CN101511826A (en) | 2009-08-19 |
| EP2081926B1 (en) | 2012-05-02 |
| EP2081926A1 (en) | 2009-07-29 |
| US7868191B2 (en) | 2011-01-11 |
| CA2649758C (en) | 2014-03-18 |
| TWI406860B (en) | 2013-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2882941B1 (en) | PROCESS FOR PURIFYING NATURAL GAS BY ADSORPTING MERCAPTANS | |
| MY160860A (en) | Natural gas purification system | |
| BRPI0803056A2 (en) | Method and installation for gas purification | |
| FR2861403B1 (en) | PROCESS FOR PURIFYING NATURAL GAS BY ADSORPTING MERCAPTANS | |
| EA201100852A1 (en) | METHOD OF MANUFACTURE OF PURIFIED NATURAL GAS | |
| EA201290015A1 (en) | COMPOSITION FOR CLEANING CARBON GASES | |
| PL2092064T3 (en) | Method for purifying rna on a preparative scale by means of hplc | |
| NO20074102L (en) | Purification of Rapamycin | |
| ATE478525T1 (en) | COMPRESSION AND MIXING FOR HEARING AIDS | |
| WO2008134048A3 (en) | Methods for synthesizing and purifying aminoalkyl tetracycline compounds | |
| EA201290005A1 (en) | WASHING COMPOSITION FOR ACID GAS CLEANING | |
| NO20070483L (en) | Process for purification of IL-18 binding protein. | |
| BRPI1008300A8 (en) | daptomycin purification process | |
| NO345118B1 (en) | Process for purifying gas mixtures containing mercaptans and other acid gases | |
| NO20062545L (en) | Process for Purification of IL-18 Binding Protein | |
| NO20091293L (en) | Preparation and purification of mupirocin calcium | |
| NO20080131L (en) | Method for Purification of IL-18 Binding Protein | |
| AR057731A1 (en) | METHOD AND SYSTEM TO PURIFY A GAS | |
| TW200709840A (en) | System and method for purifying a gas | |
| BR112012025729A2 (en) | caramel adsorption purification | |
| BR102018069428A2 (en) | improved processes using rho adsorbent compositions | |
| MY154011A (en) | Method for removing sulphur, nitrogen and halogen impurities from a synthetic gas | |
| DE602008004747D1 (en) | PROCESS FOR PURIFYING HYDROPHOUS PROTEINS | |
| EA200900065A1 (en) | INHIBITORS OF GLYCINE TRANSFER-1 | |
| EA201000464A1 (en) | METHOD FOR OBTAINING PURIFIED SYNTHESIS-GAS FROM SYNTHESIS-GAS CONTAINING THE TRACKS OF THE ADHESIVE OF SULFUR COMPOUNDS BY METAL-ORGANIC STRUCTURE |